Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celsion Initiates Phase II OVATION 2 Study of GEN-1 in Advanced Ovarian Cancer

americanpharmaceuticalreviewAugust 03, 2020

Tag: Celsion , ovarian cancer , GEN-1

PharmaSources Customer Service